Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
Christian Holm Hansen, Daniela Michlmayr, Sophie Gubbels, et al.
The Lancet (2021) Vol. 397, Iss. 10280, pp. 1204-1212
Open Access | Times Cited: 642

Showing 1-25 of 642 citing articles:

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Nuno R. Faria, Thomas A. Mellan, Charles Whittaker, et al.
Science (2021) Vol. 372, Iss. 6544, pp. 815-821
Open Access | Times Cited: 1435
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Markus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
Cell (2021) Vol. 185, Iss. 3, pp. 447-456.e11
Open Access | Times Cited: 869
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
Victoria Hall, Sarah Foulkes, Ferdinando Insalata, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 13, pp. 1207-1220
Open Access | Times Cited: 621
Diagnostics for COVID-19: moving from pandemic response to control
Rosanna W. Peeling, Dominique Heymann, Yik-Ying Teo, et al.
The Lancet (2021) Vol. 399, Iss. 10326, pp. 757-768
Open Access | Times Cited: 381
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
Juliet R. C. Pulliam, Cari van Schalkwyk, Nevashan Govender, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 341
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
Emma Pritchard, Philippa C. Matthews, Nicole Stoesser, et al.
Nature Medicine (2021) Vol. 27, Iss. 8, pp. 1370-1378
Open Access | Times Cited: 317
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
Caroline Stein, Hasan Nassereldine, Reed J D Sorensen, et al.
The Lancet (2023) Vol. 401, Iss. 10379, pp. 833-842
Open Access | Times Cited: 306
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Mahesh Shanker Dhar, Robin Marwal, Radhakrishnan VS, et al.
Science (2021) Vol. 374, Iss. 6570, pp. 995-999
Open Access | Times Cited: 289
Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden
Peter Nordström, Marcel Ballin, Anna Nordström
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 6, pp. 781-790
Open Access | Times Cited: 258
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
Deborah Cromer, Jennifer A. Juno, David S. Khoury, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 6, pp. 395-404
Open Access | Times Cited: 257
Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis
Ryan M Barber, Reed J D Sorensen, David M. Pigott, et al.
The Lancet (2022) Vol. 399, Iss. 10344, pp. 2351-2380
Open Access | Times Cited: 254
Modeling transmission of SARS-CoV-2 Omicron in China
Jun Cai, Xiaowei Deng, Juan Yang, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1468-1475
Open Access | Times Cited: 251
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 232
Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation
Brit Long, Brandon M Carius, Summer Chavez, et al.
The American Journal of Emergency Medicine (2022) Vol. 54, pp. 46-57
Open Access | Times Cited: 219
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 213
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
Floriane Gallais, Pierre Gantner, Timothée Bruel, et al.
EBioMedicine (2021) Vol. 71, pp. 103561-103561
Open Access | Times Cited: 212
Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies
Isabel Bergeri, Mairead Whelan, Harriet Ware, et al.
PLoS Medicine (2022) Vol. 19, Iss. 11, pp. e1004107-e1004107
Open Access | Times Cited: 207
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 194
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections
Sivan Gazit, Roei Shlezinger, Galit Perez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 177
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
Laith J. Abu‐Raddad, Hiam Chemaitelly, Peter Coyle, et al.
EClinicalMedicine (2021) Vol. 35, pp. 100861-100861
Open Access | Times Cited: 173
Optimal Covid-19 Quarantine and Testing Policies
Facundo Piguillem, Liyan Shi
The Economic Journal (2022) Vol. 132, Iss. 647, pp. 2534-2562
Open Access | Times Cited: 171
COVID-19 wastewater epidemiology: a model to estimate infected populations
Christopher S. McMahan, Stella Self, Lior Rennert, et al.
The Lancet Planetary Health (2021) Vol. 5, Iss. 12, pp. e874-e881
Open Access | Times Cited: 171
COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection
Kevin Escandón-Vargas, Angela L. Rasmussen, Isaac I. Bogoch, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 165
Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study
Matt D. T. Hitchings, Otávio T. Ranzani, Mario Torres, et al.
The Lancet Regional Health - Americas (2021) Vol. 1, pp. 100025-100025
Open Access | Times Cited: 160
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study
Sivan Gazit, Roei Shlezinger, Galit Perez, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e545-e551
Open Access | Times Cited: 148
Page 1 - Next Page

Scroll to top